Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Interim Management Statement

4 Nov 2015 09:16

RNS Number : 5095E
Mandarin Oriental International Ltd
04 November 2015
 



To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

4th November 2015 - Mandarin Oriental International Limited has today issued an Interim Management Statement for the third quarter of 2015.

 

Softer demand in Hong Kong and Singapore, together with disruption from the renovation in Kuala Lumpur, led to a lower overall contribution from Asia despite improved trading in Tokyo. Europe's contribution benefited from the addition of the Hotel Ritz in Madrid and improved results in London, but the overall result was lower due to softer demand in Paris and the renovation in Munich. In The Americas, positive trading momentum led to improved results across the portfolio. Notwithstanding the challenging conditions which affected a number of hotels across the portfolio, overall profitability of the Group was largely resilient.

 

In July, the Group opened the 104-room Mandarin Oriental, Milan, which was followed in October with the opening of Mandarin Oriental, Marrakech, a luxury resort with 54 private villas. In September, a management contract was announced for a 280-room hotel with 103 Residences at Mandarin Oriental in Beirut, scheduled to open in 2018.

 

The Group remains in a strong financial position, with net debt at the quarter end in line with what was reported at the half year.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. Having grown from a well-respected Asian hotel company into a global brand, the Group now operates, or has under development, 46 hotels representing more than 11,000 rooms in 25 countries, with 21 hotels in Asia, nine in The Americas and 16 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 16 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange as its primary listing, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

Brunswick Group Limited

Joanna Donne (852) 3512 5070

 

This and other Group announcements can be accessed through the internet at www.mandarinoriental.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKZLBBEFFFFBB
Date   Source Headline
23rd Jan 201910:38 amRNSShares Purchase
22nd Jan 201910:48 amRNSShares Purchase
21st Jan 201911:21 amRNSShares Purchase
20th Dec 201811:34 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:12 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
12th Oct 201812:00 pmRNSShares Purchase
10th Oct 201810:45 amRNSShares Purchase
10th Oct 201810:12 amRNSDirector/PDMR Shareholding
9th Oct 201811:03 amRNSShares Purchase
5th Oct 201810:47 amRNSShares Purchase
5th Oct 201810:36 amRNSAdditional Listing
4th Oct 201811:30 amRNSShares Purchase
3rd Oct 201811:14 amRNSShares Purchase
2nd Oct 201811:36 amRNSShares Purchase
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
26th Sep 201810:10 amRNSDividend
21st Sep 201811:33 amRNSDividend
29th Aug 201810:08 amRNSCirc re. Scrip Dividend Scheme
17th Aug 201810:26 amRNSDF Partnership With Robinsons Receive PCC Approval
27th Jul 201810:47 amRNSHalf-year Report
27th Jul 201810:41 amRNSHalf-year Report
26th Jul 201811:07 amRNSPT Astra International Tbk Half Year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
25th Jul 201810:35 amRNSFirst Half of 2018 Results of PT Hero
28th Jun 201810:11 amRNSNotice of 2018 Half-Yearly Results
7th Jun 20187:00 amRNSMandarin Oriental International Ltd Announcement
31st May 201810:25 amRNSTotal Voting Rights
16th May 201810:14 amRNSDirector/PDMR Shareholding
11th May 201810:10 amRNSAdditional Listing
10th May 20185:06 pmRNSDirectorate Change
10th May 20185:05 pmRNSResult of AGM
10th May 20185:05 pmRNSNon-Routine Resolutions submitted via NSM
10th May 201812:34 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.